.png)
.png)
Driven by rapid growth Oxford Sciences Innovation expands to The Oxford Science Park
Driven by rapid growth Oxford Sciences Innovation expands to The Oxford Science Park
OSI builds on links with Park as second occupier of prestigious Schrödinger Building
Oxford, UK, 19 April 2018 – Oxford Sciences Innovation (OSI), which invests in world-leading science and technology from the University of Oxford, is expanding at The Oxford Science Park, one of the UK's leading parks for science and technology companies. Driven by its rapid rate of growth and creation of spin-out companies, OSI is taking 17,260 sq ft of office and laboratory space on the second floor of the state-of-the-art Schrödinger Building. The space will be used by three of its spin-out companies - Orbit Discovery (peptide drugs for chronic diseases), OMass Technologies (mass spectrometry of protein complexes for drug discovery) and Vaccitech (novel vaccines for flu and cancer). They join five other OSI spin-outs on The Oxford Science Park, highlighting it as the location of choice for life science companies in Oxford.
OSI was established in 2015 to exploit and commercialise research findings from academic departments across the University. Since then it has raised over £600m and set up over 50 companies. As the portfolio companies have grown they need extra capacity and laboratory space, and The Oxford Science Park’s Schrödinger Building is the ideal location for the next phase of their growth. Vaccitech, OMass and Orbit are expected to move in during September, joining the other OSI spin-outs Evox Therapeutics, Argonaut Therapeutics, OxSight, Ultromics and Circadian Therapeutics which are already resident on the Park.
‘Having invested almost £100m in its portfolio companies since inception, OSI is a key player in the UK innovation network. The Oxford Science Park is delighted to strengthen its links with OSI and I have little doubt its spin-out companies will thrive and grow here. In addition to our exemplary working environment, our flexible leasing policy and the abundance of collaborative opportunities presented by our existing commercial eco-system support growth and value creation,’ said Piers Scrimshaw-Wright, Managing Director of The Oxford Science Park.
Carter Jonas represented The Oxford Science Park and Bidwells represented OSI.
--ENDS—
A photograph of the building is available on request.
For more information, please contact:
Oxford Sciences Innovation
Jim Wilkinson, Chief Financial Officer
[email protected]
The Oxford Science Park
Emma Palmer Foster, Strategic Communications Consultant
T: +44 (0)7880 787185
[email protected]
Notes to editors
About Oxford Sciences Innovation
Oxford Sciences Innovation (OSI) is a £600 investment company dedicated to deep science & technology emerging from Oxford. Backed by GV, Sequoia, Temasek, Tencent and Wellcome Trust among several global investors, OSI has been helping Oxford scientists address the world’s leading challenges, from infectious disease to sustainable energy since 2015.
About The Oxford Science Park
The Oxford Science Park is owned and managed by Magdalen College, Oxford. Created in 1991, the Park upholds the College’s heritage and provides one of the most influential science & technology environments in the UK. There is more than half a million square feet of workspace accommodation across the Park, which is now home to nearly 2,500 people and 80 businesses. These range from start-ups based in the Magdalen Centre innovation hub to major international companies and include Circassia, IBM, OrganOx, OxSonics, Oxford Nanopore Technologies, Sharp Laboratories, Oxford Genetics, ProImmune and Oxford Technology Management.
In addition to being a key property investment, the Park is at the heart of Magdalen College's strategy to support discovery, innovation and entrepreneurship. It will continue to develop The Oxford Science Park as a long-term strategic asset, with ambitious plans to create an additional 300,000+ sq ft of office and laboratory space on the remaining 10+ acres of land over the next 3-5 years. This additional capacity will support the growth of businesses already based on the Park, providing flexible workspace accommodation, and enabling new companies to enjoy the Park’s exceptional environment and collegiate and collaborative ethos.
The Oxford Science Park is located approximately four miles south-east of Oxford city centre, just off the City’s southern ring road. It has easy access to the M40 and A34, as well as to Heathrow Airport and mainline train services. For further information, please visit: www.oxfordsp.com or follow us on twitter @OxfordSciencePK
OSI builds on links with Park as second occupier of prestigious Schrödinger Building
Oxford, UK, 19 April 2018 – Oxford Sciences Innovation (OSI), which invests in world-leading science and technology from the University of Oxford, is expanding at The Oxford Science Park, one of the UK's leading parks for science and technology companies. Driven by its rapid rate of growth and creation of spin-out companies, OSI is taking 17,260 sq ft of office and laboratory space on the second floor of the state-of-the-art Schrödinger Building. The space will be used by three of its spin-out companies - Orbit Discovery (peptide drugs for chronic diseases), OMass Technologies (mass spectrometry of protein complexes for drug discovery) and Vaccitech (novel vaccines for flu and cancer). They join five other OSI spin-outs on The Oxford Science Park, highlighting it as the location of choice for life science companies in Oxford.
OSI was established in 2015 to exploit and commercialise research findings from academic departments across the University. Since then it has raised over £600m and set up over 50 companies. As the portfolio companies have grown they need extra capacity and laboratory space, and The Oxford Science Park’s Schrödinger Building is the ideal location for the next phase of their growth. Vaccitech, OMass and Orbit are expected to move in during September, joining the other OSI spin-outs Evox Therapeutics, Argonaut Therapeutics, OxSight, Ultromics and Circadian Therapeutics which are already resident on the Park.
‘Having invested almost £100m in its portfolio companies since inception, OSI is a key player in the UK innovation network. The Oxford Science Park is delighted to strengthen its links with OSI and I have little doubt its spin-out companies will thrive and grow here. In addition to our exemplary working environment, our flexible leasing policy and the abundance of collaborative opportunities presented by our existing commercial eco-system support growth and value creation,’ said Piers Scrimshaw-Wright, Managing Director of The Oxford Science Park.
Carter Jonas represented The Oxford Science Park and Bidwells represented OSI.
--ENDS—
A photograph of the building is available on request.
For more information, please contact:
Oxford Sciences Innovation
Jim Wilkinson, Chief Financial Officer
[email protected]
The Oxford Science Park
Emma Palmer Foster, Strategic Communications Consultant
T: +44 (0)7880 787185
[email protected]
Notes to editors
About Oxford Sciences Innovation
Oxford Sciences Innovation (OSI) is a £600 investment company dedicated to deep science & technology emerging from Oxford. Backed by GV, Sequoia, Temasek, Tencent and Wellcome Trust among several global investors, OSI has been helping Oxford scientists address the world’s leading challenges, from infectious disease to sustainable energy since 2015.
About The Oxford Science Park
The Oxford Science Park is owned and managed by Magdalen College, Oxford. Created in 1991, the Park upholds the College’s heritage and provides one of the most influential science & technology environments in the UK. There is more than half a million square feet of workspace accommodation across the Park, which is now home to nearly 2,500 people and 80 businesses. These range from start-ups based in the Magdalen Centre innovation hub to major international companies and include Circassia, IBM, OrganOx, OxSonics, Oxford Nanopore Technologies, Sharp Laboratories, Oxford Genetics, ProImmune and Oxford Technology Management.
In addition to being a key property investment, the Park is at the heart of Magdalen College's strategy to support discovery, innovation and entrepreneurship. It will continue to develop The Oxford Science Park as a long-term strategic asset, with ambitious plans to create an additional 300,000+ sq ft of office and laboratory space on the remaining 10+ acres of land over the next 3-5 years. This additional capacity will support the growth of businesses already based on the Park, providing flexible workspace accommodation, and enabling new companies to enjoy the Park’s exceptional environment and collegiate and collaborative ethos.
The Oxford Science Park is located approximately four miles south-east of Oxford city centre, just off the City’s southern ring road. It has easy access to the M40 and A34, as well as to Heathrow Airport and mainline train services. For further information, please visit: www.oxfordsp.com or follow us on twitter @OxfordSciencePK